[{"Assets_0_FY_USD":5611068000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":285494000.0,"NetIncomeLossConverted_4_FY_USD":365614000.0,"NetIncomeLossConverted_1_FY_USD":-828500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":30228000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":29836000.0,"StockholdersEquity_0_FY_USD":4020331000.0,"EarningsPerShareBasic_1_FY_USD":-27.73,"EarningsPerShareBasic_4_FY_USD":12.25,"EarningsPerShareDiluted_1_FY_USD":-27.73,"EarningsPerShareDiluted_4_FY_USD":12.1,"RevenuesConverted_1_FY_USD":616900000.0,"RevenuesConverted_4_FY_USD":2289415000.0,"Ticker":"BIO_2","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20190401"}]